Substance P and NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 280, Issue 1 49-1, 2001, Pages

  Kapoor, John R ^a   Sladek, Celia D ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b The Chicago Medical College   (United States)

Author keywords

A1 neurons; Hemodynamic regulation; Neurohypophysis; Norepinephrine; Supraoptic nucleus

Indexed keywords

ADENOSINE TRIPHOSPHATE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; OXYTOCIN; SUBSTANCE P; VASOPRESSIN;

ADRENERGIC STIMULATION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; RAT; SUPRAOPTIC NUCLEUS; VASOPRESSIN RELEASE;

EID: 0035020824     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2001.280.1.r69     Document Type: Article

References (56)

1. 1receptor. Brain Res 365: 192-197, 1986.
2. Bartfai T, Iverfeldt K, Fisone G, and Serfozo P. Regulation of the release of coexisting neurotransmitters. Annu Rev Pharmacol Toxicol 28: 285-310, 1988.
3. Beroukas D, Willoughby JO, and Blessing WW. Neuropeptide Y-like immunoreactivity is present in boutons synapsing on vasopressin-containing neurons in rabbit supraoptic nucleus. Neuroendocrinology 50: 222-228, 1989.
4. Bittencourt JC, Benoit R, and Sawchenko PE. Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: partial overlap with ascending catecholaminergic projections. J Chein Neuroanat 4: 63-78, 1991.
5. Blessing WW, Howe PRC, Job TH, Oliver JR, and Willoughby JO. Distribution of tyrosine hydroxylase and neuropeptide Y-like immunoreactive neurons in rat medulla oblongata, with attention to colocalization studies, presumptive adrenaline-synthesizing perikarya, and vagal pre-ganglionic neurons. J Comp Neuro 248: 285-300, 1986.
6. Buller K, Khanna S, Sibbald J, and Day TR. Central noradrenergic neurons signal via ATP to elicit vasopressin responses to haemorrhage. Neuroscience 73: 637-642, 1996.
7. Chen ZP, Levy A, and Lightman SL. Nucleotides as extracellular signalling molecules. J Neuroendocrinol 7: 83-96, 1995.
8. Chowdrey HS, Jessop DS, and Lightman SL. Substance P stimulates arginine vasopressin and inhibits adrenocorticotropin release in vivo in the rat. Neuroendocrinology 52: 90-93, 1990.
9. Cunningham ET Jr and Sawchenko PE. Reflex control of magnocellular vasopressin and oxytocin secretion. Trends Neurosci 14: 406-411, 1991.
10. Daftary S, Boudaba C, Szabo K, and Tasker J. Noradrenergic excitation of magnocellular neurons in the rat hypothalamic paraventricular nucleus via intranuclear glutamatergic circuits. J Neurosci 18: 10619-10628, 1998.
11. 3H]senktide. Brain Res 506: 176-179, 1990.
12. Day TA, Randle JCR, and Renaud LP. Opposing alpha- and beta-adrenergic mechanisms mediate dose-dependent actions of noradrenaline on supraoptic vasopressin neurons in vivo. Brain Res 358: 171-179, 1985.
13. Day TA, Renaud LP, and Sibbald JR. Excitation of supraoptic vasopressin cells by stimulation of the A1 noradrenaline cell group: failure to demonstrate role for established adrenergic or amino acid receptors. Brain Res 516: 91-98, 1990.
14. Day TA and Sibbald JR. Involvement of the A1 cell group in baroreceptor inhibition of neurosecretory vasopressin cells. Neurosci Lett 113: 156-162, 1990.
15. Day TA, Sibbald JR, and Khanna S. ATP mediates an excitatory noradrenergic neuron input to supraoptic vasopressin cells. Brain Res 607: 341-344, 1993.
16. Ding YQ, Shigemoto R, Takada M, Ohishi H, Nakanishi S, and Mizuno N. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J Comp Neuro 364: 290-310, 1996.
17. Eguchi T, Takano T, Hatae T, Saito R, Nakayama Y, Shigeyoshi Y, Okamura H, Krause J, and Kamiya H. Antidiuretic action of tachykinin NK-3 receptor in the rat paraventricular nucleus. Brain Res 743: 49-55, 1996.
18. Everitt BJ, Hokfelt T, Terenius L, Tatemoto K, Mutt V, and Goldstein M. Differential coexistence of neuropeptide Y (NPY)-lke immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11: 443-462, 1984.
19. Feuerstein G, Heike C, and Faden AI. Differential changes in substance P and somatostatin in brain nuclei of rats exposed to hemorrhagic shock. Brain Res 300: 305-310, 1984.
20. Goo Rhee S and Soo Bae Y. Regulation of phosphoinositide-specific phospholipase C isoenzymes. J Biol Chem 272: 15045-15048, 1997.
21. Heike Y, Hisano S, Tsurvo Y, Katoh S, and Daikoku S. Immunocytochemical evidence for synaptic regulation of paraventricular vasopressin-containing neurons by substance P. Brain Res 369: 341-346, 1986.
22. Herzog H, Hort Y, Ball H, Hayes G, Shine J, and Selbie L. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 89: 5794-5798, 1992.
23. Hiruma H and Bourque CW. P2 purinoceptor-mediated depolarization of rat supraoptic neurosecretory cells in vitro. J Physiol (Lod) 489: 805-811, 1995.
24. Holtback U, Brismar H, Fu DGM, Greengard P, and Aperia A. Receptor recruitment: a mechanism for interactions between G protein-coupled receptors. Proc Natl Acad Sci USA 96: 7271-7275, 1999.
25. Holzbauer M, Donnerer J, Holzer P, and Schluet W. Immunoreactive substance P in the tubero-hypophyseal system of the rat: selective decrease in the neural lobe after dehydration and salt loading. Neurosci Lett 47: 23-28, 1984.
26. Idriss HT, Hannun YA, Boulpaep E, and Basavappa S. Regulation of volume-activated chloride channels by P-glycoprotein: phosphorylation has the final say! J Physiol (Lond) 524: 629-636, 2000.
27. Kapoor JR and Sladek CD. Purinergic and adrenergic agonists synergize in stimulating vasopressin and oxytocin release. J Neurosci. In press.
28. Kapoor JR and Sladek CD. Role of ATP in the regulation of vasopressin release (Abstract). FASEB J 13: A1061, 1999.
29. Khanna S, Sibbald JR, and Day TA. Neuropeptide Y modulation of Al noradrenergic neuron input to supraoptic vasopressin cells. Neurosci Lett 161: 60-64, 1993.
30. Larsen PJ. Distribution of substance P-immunoreactive elements in the preoptic area and the hypothalamus of the rat. J Comp Neurol 316: 287-313, 1992.
31. Larsen PJ, Jukes KE, Chowdrey HS, Lightman SL, and Jessop DS. Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland. Endocrinology 134: 1635-1639, 1994.
32. Larsen PJ, Sheikh SP, and Mikkelsen JD. Osmotic regulation of neuropeptide Y and its binding sites in the magnocellular hypothalamo-neurohypophysial pathway. Brain Res 573: 181-189, 1992.
33. Ljungdahl A, Hokfelt T, and Nilsson G. Distribution of substance P-like immunoreactivity in the central nervous system of the rat. I. Cell bodies and nerve terminals. Neuroscience 3: 861-880, 1978.
34. Marksteiner J, Sperk G, and Krause J. Distribution of neurons expressing neurokinin B in the rat brain: immunohistochemistry and in situ hybridization. J Comp Neurol 317: 341-356, 1992.
35. Michel M. Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol Sci 12: 389-394, 1991.
36. Mori M, Tsushima H, and Matsuda T. Substance P injected into the hypothalamic supraoptic nucleus causes antidiuresis through the release of arginine-vasopressin in water-loaded and ethanol-anesthetized rats. Jpn J Pharmacol 62: 49-56, 1993.
37. Nakajima Y, Tsuchida K, Negishi M, Ito S, and Nakanishi S. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J Biol Chem 267: 2437-2442, 1992.
38. Pellieux C, Sauthier T, Domenighetti A, Marsh D, Palmiter R, Brunner HR, and Pedrazzini T. Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Proc Natl Acad Sci USA 97: 1595-1600, 1999.
39. Sawchenko PE, Swanson LW, Grzanna R, Howe PRC, Polak JM, and Bloom SR. Co-localization of neuropeptide-Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241: 138-153, 1985.
40. Selbie L, Darby K, Schmitz-Peiffer C, Browne C, Herzog H, Shine J, and Biden T. Synergistic interaction of the Y1-neuropeptide Y and α1b-adrenergic receptors in the regulation of phospholipase C, protein kinase C and arachidonic acid production. J Biol Chem 270: 11789-11796, 1995.
41. Shughrue PJ, Lane MV, and Merchenthaler I. In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system. J Comp Neurol 372: 395-414, 1996.
42. Sibbald JR, Wilson BKJ, and Day TA. Neuropeptide Y potentiates excitation of supraoptic neurosecretory cells by noradrenaline. Brain Res 499: 164-168, 1989.
43. Sladek C. Antidiuretic hormone: synthesis and release. In: Handbook of Physiology. The Endocrine System. Endocrine Regulation of Water and Electrolyte Balance. Bethesda, MD: Am. Physiol. Soc., 2000, sect. 7, vol. III, chapt. 12, p. 436-475.
44. Sladek C. Regulation of vasopressin release by neurotransmitters, neuropeptides and osmotic stimuli. Prog Brain Res 60: 71-90, 1983.
45. Sladek C and Armstrong WE. Neural pathways subserving osmotic control of vasopressin release. In: Vasopressin, edited by Schrier RW. New York: Raven, 1985, p. 435-441.
46. Sladek C, Fisher K, Sidorowicz HE, and Mathiasen JR. cAMP regulation of vasopressin mRNA content in hypothalamoneurohypophysial explants. Am J Physiol Regulatory Integrative Comp Physiol 271: R554-R560, 1996.
47. Sladek CD, Badre SE, Morsette DJ, and Sidorowicz HE. Role of Non-NMDA receptors in osmotic and glutamate stimulation of vasopressin release: effect of rapid receptor desensitization. J Neuroendocrinol 10: 897-903, 1998.
48. 3H]noradrenaline from rat hypothalamic slices: origin and modulation by α2-adrenoceptors. Neuroscience 82: 511-520, 1998.
49. Sun L, Rybin V, Steinberg S, and Robinson R. Characterization of the alphal-adrenergic chronotropic response in neuropeptide Y-treated cardiomyocytes. Eur J Pharmacol 349: 377-381, 1998.
50. Swenson KL, Badre SE, Morsette DJ, and Sladek CD. N-methyl-D-aspartic acid stimulation of vasopressin release: role in osmotic regulation and modulation by gonadal steroids. J Neuroendocrinol 10: 679-685, 1998.
51. Tien X, Brasitus T, Kaetzel M, Dedman J, and Nelson D. Activation of the cystic fibrosis transmembrane conductance regulator by cGMP in the human colonic cancer cell line, Caco-2. J Biol Chem 269: 51-54, 1994.
52. Van Sande J, Raspe E, Perret J, Lejeune C, Maenhaut C, Vassart G, and Dumont JE. Thyrotropin activates both the cyclic AMP and the PiP2 cascades in CHO cells expressing the human cDNA of TSH receptor. Mol Cell Endocrinol 74: R1-R6, 1990.
53. 2+-dependent transmitter release. Prog Neurobiol 42: 539-574, 1994.
54. Warden M and Young W. Distribution of cells containing mRNAs encoding substance P and neurokinin B in the rat central nervous system. J Comp Neurol 272: 90-113, 1988.
55. Willoughby JO and Blessing WW. Neuropeptide Y injected into the supraoptic nucleus causes secretion of vasopressin in the unanesthetized rat. Neurosci Lett 75: 17-22, 1987.
56. Yagil C and Sladek CD. Osmotic regulation of vasopressin and oxytocin release is rate sensitive in the hypothalamoneurohypophysial explants. Am J Physiol Regulatory Integrative Comp Physiol 258: R492-R500, 1990.